S 641 ยท Safe and Affordable Drugs from Canada Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced
- Feb 19, 2025
- Latest action
- Feb 19, 2025
- Sponsor
- Sen. Amy Klobuchar [D-MN]
- Policy area
- Health
- Cosponsors
- 7
Summary
Safe and Affordable Drugs from Canada Act of 2025 This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances. Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs. An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs. The FDA must publish a list of approved Canadian pharmacies on its website.
Recent actions
- Feb 19, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Feb 19, 2025 Introduced in Senate
Votes
No recorded votes are available for this bill.